AbbVie Inc. Amortization of Intangible Assets
AbbVie Inc. (ABBV) reported Amortization of Intangible Assets of $1.70 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-03
- AbbVie Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $1.70B, a 10.53% decline year-over-year.
- AbbVie Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $1.75B, a 5.92% decline year-over-year.
- AbbVie Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $1.78B, a 5.91% decline year-over-year.
- AbbVie Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $1.90B, a 0.00% change year-over-year.
- AbbVie Inc. amortization of intangible assets for fiscal 2025 was $7.38B, a 3.21% decline from fiscal 2024.
- AbbVie Inc. amortization of intangible assets for fiscal 2024 was $7.62B, a 4.08% decline from fiscal 2023.
- AbbVie Inc. amortization of intangible assets for fiscal 2023 was $7.95B, a 3.34% increase from fiscal 2022.
- AbbVie Inc. amortization of intangible assets for fiscal 2022 was $7.69B, a 0.38% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.70B 10-Q · filed 2026-08-03 | $3.44B 10-Q · filed 2026-08-03 | $5.23B derived: sum of 3 quarters · filed 2026-08-03 | $7.13B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $1.75B 10-Q · filed 2026-05-08 | $3.53B derived: sum of 2 quarters · filed 2026-05-08 | $5.43B derived: sum of 3 quarters · filed 2026-05-08 | $7.33B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $1.78B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.68B derived: sum of 2 quarters · filed 2026-02-20 | $5.58B derived: sum of 3 quarters · filed 2026-08-03 | $7.38B 10-K · filed 2026-02-20 |
| 2025-09-30 | $1.90B 10-Q · filed 2025-11-04 | $3.80B derived: sum of 2 quarters · filed 2026-08-03 | $5.59B 10-Q · filed 2025-11-04 | $7.55B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $1.90B 10-Q · filed 2026-08-03 | $3.72B 10-Q · filed 2026-08-03 | $5.65B derived: sum of 3 quarters · filed 2026-08-03 | $7.55B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $1.86B 10-Q · filed 2026-05-08 | $3.75B derived: sum of 2 quarters · filed 2026-05-08 | $5.65B derived: sum of 3 quarters · filed 2026-05-08 | $7.55B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.90B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.80B derived: sum of 2 quarters · filed 2026-02-20 | $5.70B derived: sum of 3 quarters · filed 2026-02-20 | $7.62B 10-K · filed 2026-02-20 |
| 2024-09-30 | $1.90B 10-Q · filed 2025-11-04 | $3.80B derived: sum of 2 quarters · filed 2025-11-04 | $5.73B 10-Q · filed 2025-11-04 | $7.58B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $1.90B 10-Q · filed 2025-08-04 | $3.84B 10-Q · filed 2025-08-04 | $5.68B derived: sum of 3 quarters · filed 2026-02-20 | $7.68B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $1.89B 10-Q · filed 2025-05-09 | $3.78B derived: sum of 2 quarters · filed 2026-02-20 | $5.78B derived: sum of 3 quarters · filed 2026-02-20 | $7.88B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $1.89B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.89B derived: sum of 2 quarters · filed 2026-02-20 | $5.99B derived: sum of 3 quarters · filed 2026-02-20 | $7.95B 10-K · filed 2026-02-20 |
| 2023-09-30 | $2.00B 10-Q · filed 2024-11-04 | $4.10B derived: sum of 2 quarters · filed 2024-11-04 | $6.06B 10-Q · filed 2024-11-04 | $8.01B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $2.10B 10-Q · filed 2024-08-07 | $4.02B 10-Q · filed 2024-08-07 | $6.01B derived: sum of 3 quarters · filed 2025-02-14 | $8.01B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $1.95B 10-Q · filed 2024-05-03 | $3.91B derived: sum of 2 quarters · filed 2025-02-14 | $5.91B derived: sum of 3 quarters · filed 2025-02-14 | $7.71B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $1.96B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $3.96B derived: sum of 2 quarters · filed 2025-02-14 | $5.76B derived: sum of 3 quarters · filed 2025-02-14 | $7.69B 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.00B 10-Q · filed 2023-11-06 | $3.80B derived: sum of 2 quarters · filed 2023-11-06 | $5.73B 10-Q · filed 2023-11-06 | $7.46B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $1.80B 10-Q · filed 2023-08-07 | $3.70B 10-Q · filed 2023-08-07 | $5.46B derived: sum of 3 quarters · filed 2024-02-20 | $7.36B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $1.85B 10-Q · filed 2023-05-05 | $3.66B derived: sum of 2 quarters · filed 2024-02-20 | $5.56B derived: sum of 3 quarters · filed 2024-02-20 | $7.56B derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.81B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.71B derived: sum of 2 quarters · filed 2024-02-20 | $5.71B derived: sum of 3 quarters · filed 2024-02-20 | $7.72B 10-K · filed 2024-02-20 |
| 2021-09-30 | $1.90B 10-Q · filed 2022-11-04 | $3.90B derived: sum of 2 quarters · filed 2022-11-04 | $5.91B 10-Q · filed 2022-11-04 | $7.75B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $2.00B 10-Q · filed 2022-08-04 | $4.01B 10-Q · filed 2022-08-04 | $5.85B derived: sum of 3 quarters · filed 2023-02-17 | $7.95B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $2.01B 10-Q · filed 2022-05-06 | $3.85B derived: sum of 2 quarters · filed 2023-02-17 | $5.95B derived: sum of 3 quarters · filed 2023-02-17 | $7.35B derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $3.94B derived: sum of 2 quarters · filed 2023-02-17 | $5.34B derived: sum of 3 quarters · filed 2023-02-17 | $5.80B 10-K · filed 2023-02-17 |
| 2020-09-30 | $2.10B 10-Q · filed 2021-11-02 | $3.50B derived: sum of 2 quarters · filed 2021-11-02 | $3.97B 10-Q · filed 2021-11-02 | $4.33B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $1.40B 10-Q · filed 2021-08-02 | $1.85B 10-Q · filed 2021-08-02 | $2.23B derived: sum of 3 quarters · filed 2022-02-18 | $2.62B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $444.00M 10-Q · filed 2021-05-07 | $835.00M derived: sum of 2 quarters · filed 2022-02-18 | $1.22B derived: sum of 3 quarters · filed 2022-02-18 | $1.61B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $391.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $780.00M derived: sum of 2 quarters · filed 2022-02-18 | $1.17B derived: sum of 3 quarters · filed 2022-02-18 | $1.55B 10-K · filed 2022-02-18 |
| 2019-09-30 | $389.00M 10-Q · filed 2020-11-04 | $777.00M derived: sum of 2 quarters · filed 2020-11-04 | $1.16B 10-Q · filed 2020-11-04 | $1.48B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $388.00M 10-Q · filed 2020-08-04 | $773.00M 10-Q · filed 2020-08-04 | $1.09B derived: sum of 3 quarters · filed 2021-02-19 | $1.41B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $385.00M 10-Q · filed 2020-05-08 | $705.00M derived: sum of 2 quarters · filed 2021-02-19 | $1.02B derived: sum of 3 quarters · filed 2021-02-19 | $1.35B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $320.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $640.00M derived: sum of 2 quarters · filed 2021-02-19 | $964.00M derived: sum of 3 quarters · filed 2021-02-19 | $1.29B 10-K · filed 2021-02-19 |
| 2018-09-30 | $320.00M 10-Q · filed 2019-11-06 | $644.00M derived: sum of 2 quarters · filed 2019-11-06 | $974.00M 10-Q · filed 2019-11-06 | $1.24B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $324.00M 10-Q · filed 2019-08-05 | $654.00M 10-Q · filed 2019-08-05 | $922.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.19B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $330.00M 10-Q · filed 2019-05-03 | $598.00M derived: sum of 2 quarters · filed 2020-02-21 | $866.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.14B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $268.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $536.00M derived: sum of 2 quarters · filed 2020-02-21 | $805.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.08B 10-K · filed 2020-02-21 |
| 2017-09-30 | $268.00M 10-Q · filed 2018-11-07 | $537.00M derived: sum of 2 quarters · filed 2018-11-07 | $808.00M 10-Q · filed 2018-11-07 | $1.02B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $269.00M 10-Q · filed 2018-08-07 | $540.00M 10-Q · filed 2018-08-07 | $750.00M derived: sum of 3 quarters · filed 2019-02-27 | $958.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $271.00M 10-Q · filed 2018-05-04 | $481.00M derived: sum of 2 quarters · filed 2019-02-27 | $689.00M derived: sum of 3 quarters · filed 2019-02-27 | $870.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $210.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $418.00M derived: sum of 2 quarters · filed 2019-02-27 | $599.00M derived: sum of 3 quarters · filed 2019-02-27 | $764.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $208.00M 10-Q · filed 2017-11-07 | $389.00M derived: sum of 2 quarters · filed 2017-11-07 | $554.00M 10-Q · filed 2017-11-07 | $694.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $181.00M 10-Q · filed 2017-08-07 | $346.00M 10-Q · filed 2017-08-07 | $486.00M derived: sum of 3 quarters · filed 2018-02-16 | $611.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $165.00M 10-Q · filed 2017-05-05 | $305.00M derived: sum of 2 quarters · filed 2018-02-16 | $430.00M derived: sum of 3 quarters · filed 2018-02-16 | $516.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $140.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $265.00M derived: sum of 2 quarters · filed 2018-02-16 | $351.00M derived: sum of 3 quarters · filed 2018-02-16 | $419.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | $125.00M 10-Q · filed 2016-11-07 | $211.00M derived: sum of 2 quarters · filed 2016-11-07 | $279.00M 10-Q · filed 2016-11-07 | $375.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $86.00M 10-Q · filed 2016-08-05 | $154.00M 10-Q · filed 2016-08-05 | $250.00M derived: sum of 3 quarters · filed 2017-02-17 | $348.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $68.00M 10-Q · filed 2016-05-06 | $164.00M derived: sum of 2 quarters · filed 2017-02-17 | $262.00M derived: sum of 3 quarters · filed 2017-02-17 | $361.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $194.00M derived: sum of 2 quarters · filed 2017-02-17 | $293.00M derived: sum of 3 quarters · filed 2017-02-17 | $403.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | $98.00M 10-Q · filed 2015-11-06 | $197.00M derived: sum of 2 quarters · filed 2015-11-06 | $307.00M 10-Q · filed 2015-11-06 | $408.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $99.00M 10-Q · filed 2015-08-07 | $209.00M 10-Q · filed 2015-08-07 | $310.00M derived: sum of 3 quarters · filed 2016-02-19 | $447.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $110.00M 10-Q · filed 2015-05-08 | $211.00M derived: sum of 2 quarters · filed 2016-02-19 | $348.00M derived: sum of 3 quarters · filed 2016-02-19 | $484.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $101.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $238.00M derived: sum of 2 quarters · filed 2016-02-19 | $374.00M derived: sum of 3 quarters · filed 2016-02-19 | $509.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | $137.00M 10-Q · filed 2014-11-07 | $273.00M derived: sum of 2 quarters · filed 2014-11-07 | $408.00M 10-Q · filed 2014-11-07 | $544.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $136.00M 10-Q · filed 2014-08-07 | $271.00M 10-Q · filed 2014-08-07 | $407.00M derived: sum of 3 quarters · filed 2015-02-20 | $541.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $135.00M 10-Q · filed 2014-05-09 | $271.00M derived: sum of 2 quarters · filed 2015-02-20 | $405.00M derived: sum of 3 quarters · filed 2015-02-20 | $581.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | $136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $270.00M derived: sum of 2 quarters · filed 2015-02-20 | $446.00M derived: sum of 3 quarters · filed 2015-02-20 | $625.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | $134.00M 10-Q · filed 2013-11-12 | $310.00M derived: sum of 2 quarters · filed 2013-11-12 | $489.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $176.00M 10-Q · filed 2013-08-09 | $355.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $179.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $764.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |